| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |